<img src="/patient-care/conditions-diseases/IBD.jpg" style="width: 128px; height: 128px;" />
<h2>IBD</h2>

<p>The two inflammatory bowel diseases (IBD) are Crohn&rsquo;s disease and ulcerative colitis (UC). Most care for these chronic
    diseases occurs in the outpatient setting, with hospitalizations reserved for complications that might require surgery.
    AGA offers a guideline on drug therapy and decision support tools for patient management.</p>


<h3>Crohn&rsquo;s Disease</h3>

<p>Guidelines for the Identification, Assessment and Initial Medical Treatment in Crohn&rsquo;s Disease</p>

<p>
    <a href="http://cpms.bbinfotech.com/clients/aga_web_tools/interactive_0000542.html" target="_top">Interactive Clinical Care Pathway</a> |
    <a href="http://campaigns.gastro.org/algorithms/IBDCarePathway/pdf/IBDCarePathway.pdf" target="_top">Clinical Care Pathway</a>
</p>

<h3>Drug Therapy for Crohn&rsquo;s</h3>

<p>Inflammatory Crohn&rsquo;s Disease: Thiopurines, Methotrexate and Anti-TNF-&alpha; Biologic Drugs for Induction and Maintenance
    of Remission</p>

<p>
    <a href="/guidelines/2014/03/04/drug-therapy-for-crohn-s" target="_top">Guideline</a> |
    <a href="http://campaigns.gastro.org/algorithms/crohns/crohns_aga_branded_algorithm_web.pdf" target="_top">Algorithm</a> |
    <a href="http://cpms.bbinfotech.com/clients/aga_web_tools/interactive_0000543.html" target="_top">Interactive Algorithm</a> |
    <a href="http://www.gastro.org/info_for_patients/crohn-s-disease-is-an-immune-disorder-a-patient-guide" target="_top">Patient Guide</a> |
    <a href="http://cpms.bbinfotech.com/clients/aga_web_tools/ENAS5164_1.1.0.0.html" target="_top">Recommendations</a> |
    <a href="http://download.journals.elsevierhealth.com/pdfs/journals/0016-5085/PIIS0016508513015205.pdf" target="_top">Technical Review</a>
</p>

<h3>Ulcerative Colitis</h3>

<p>Identification, Assessment and Initial Medical Treatment of Ulcerative Colitis</p>

<p>
    <a href="http://campaigns.gastro.org/algorithms/UlcerativeColitis/" target="_top">Clinical Care Pathway</a> |
    <a href="https://s3.amazonaws.com/aga-guidelines/pdf/ibd/Ulcerative_Colitis_Care_Pathway.pdf" target="_top">Algorithm</a>
</p>

<h3>Medical Management of Microscopic Colitis</h3>

<p>
    <a href="/guidelines/management-of-microscopic-colitis" target="_top">Guideline</a> |
    <a href="http://www.gastrojournal.org/article/S0016-5085(15)01625-X/pdf" target="_top">PDF</a> |
    <a href="http://www.gastrojournal.org/article/S0016-5085(15)01623-6/fulltext">Technical Review</a> |
    <a href="https://s3.amazonaws.com/agaassets/pdf/guidelines/Microscopic+Colitis+CDST_Web+version_FINAL.PDF" target="_top">Algorithm</a> |
    <a href="http://52.58.211.10/clients/aga/interactive_0000916.html" target="_top">Interactive Algorithm</a> |
    <a href="/info_for_patients/managing-microscopic-colitis-a-patient-guide" target="_top">Patient Guide</a> |
    <a href="http://52.58.211.10/clients/aga/ENAS5259_1.1.0.0.html" target="_top">Recommendations</a>
</p>

<h3>Management of Crohn&#39;s Disease After Surgery</h3>

<p>
    <a href="/guidelines/chrons-disease-after-surgical-resection" target="_top">Guideline</a> |
    <a href="http://www.gastrojournal.org/article/S0016-5085(16)35285-4/pdf">PDF</a> |
    <a href="/crohnsaftersurgerytool" target="_top">Algorithm</a> |
    <a href="http://www.gastrojournal.org/article/S0016-5085(16)35286-6/pdf" target="_top">Technical Review</a>&nbsp;|
    <a href="http://www.gastro.org/info_for_patients/ibd-114-managing-crohn-s-disease-after-surgery" target="_top">Patient Guide</a>
</p>

<h3>Therapeutic Drug Monitoring in IBD</h3>
<!-- <p>Expected Summer 2017</p> -->

<p>
    <a href="http://www.gastrojournal.org/article/S0016-5085(17)35963-2/fulltext">Guideline</a> |
    <a href="http://www.gastrojournal.org/article/S0016-5085(17)35963-2/pdf">PDF</a> |
    <a href="http://www.gastrojournal.org/article/S0016-5085(17)35962-0/fulltext">Technical Review</a> |
    <a href="http://www.gastrojournal.org/article/S0016-5085(17)35970-X/pdf">Algorithm</a> |
    <a href="http://www.gastro.org/info_for_patients/ibd-115-therapeutic-drug-monitoring-in-ibd">Patient Guide</a>
</p>

<p style="text-align:left; font-size:14px;">
    <i>Please note that the above guidelines do not include recommendations for the use of newer drugs approved for the treatment
        of IBD (i.e., vedolizumab, ustekinumab) due to a lack of currently availability evidence from which to draw recommendations.
        All guidelines are regularly assessed for update as new data are published.</i>
</p>